 |
인쇄하기
취소
|
Factive to launch in the U. S. markets.
LG Life Science (President: Yang Heung-joon) announced that Factive, an antibacterial quinolone, would launch it's commercial release anytime soon after the U. S. FDA approval in April this year.
The market volume of the quinolone anti-bacterial drugs a year in the United States estimated about 3.3 billion dollars, the top market all over the world.
LG Life Science said "Oscient Inc., a ...
The market volume of the quinolone anti-bacterial drugs a year in the United States estimated about 3.3 billion dollars, the top market all over the world.
LG Life Science said "Oscient Inc., a ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.